Literature DB >> 22395003

Is there a core neuropsychiatric phenotype in 22q11.2 deletion syndrome?

Kate Baker1, Jacob A S Vorstman.   

Abstract

PURPOSE OF REVIEW: The aim is to discuss the clinical features of psychiatric illness in 22q11.2 deletion syndrome (22q11DS), and to review current evidence that a core neuropsychiatric phenotype could underlie the full spectrum of different presentations. RECENT
FINDINGS: Individuals carrying the 22q11.2 microdeletion are at risk for diverse psychiatric diagnoses across the lifespan, including schizophrenia in a significant minority, and anxiety or mood disorder in the majority. Symptoms and cognitive disruptions can be grouped into domains: attention-executive deficits, social-cognitive deficits, anxiety-affective dysregulation, and psychotic phenomena. These domains do not respect the boundaries of traditional diagnostic categories, and can be consistently recognized in children, adolescents and adults. There is early evidence that some symptom-domain disruptions may predict adult psychiatric morbidity.
SUMMARY: If a core neuropsychiatric phenotype does exist in 22q11DS, its detection is likely to require dimensional assessment of subtle aspects of cognitive and emotional processing, not encompassed by current diagnostic systems. A core phenotype would account for disruptions across multiple symptom domains, directly reflecting genetic and neurobiological mechanisms. Relative severity of a core phenotype would predict risk for multiple psychiatric disorders, and could, therefore, be an important target for therapeutic and preventive interventions. A core phenotype meeting these criteria has not yet been defined for 22q11DS.

Entities:  

Mesh:

Year:  2012        PMID: 22395003     DOI: 10.1097/WCO.0b013e328352dd58

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  28 in total

Review 1.  The 22q11.2 deletion syndrome as a window into complex neuropsychiatric disorders over the lifespan.

Authors:  Rachel K Jonas; Caroline A Montojo; Carrie E Bearden
Journal:  Biol Psychiatry       Date:  2013-08-28       Impact factor: 13.382

2.  Neural substrates of inhibitory control deficits in 22q11.2 deletion syndrome.

Authors:  C A Montojo; M Jalbrzikowski; E Congdon; S Domicoli; C Chow; C Dawson; K H Karlsgodt; R M Bilder; C E Bearden
Journal:  Cereb Cortex       Date:  2013-10-31       Impact factor: 5.357

Review 3.  Understanding the pediatric psychiatric phenotype of 22q11.2 deletion syndrome.

Authors:  Ania M Fiksinski; Maude Schneider; Clodagh M Murphy; Marco Armando; Stefano Vicari; Jaume M Canyelles; Doron Gothelf; Stephan Eliez; Elemi J Breetvelt; Celso Arango; Jacob A S Vorstman
Journal:  Am J Med Genet A       Date:  2018-09-08       Impact factor: 2.802

4.  Neurocognitive development in 22q11.2 deletion syndrome: comparison with youth having developmental delay and medical comorbidities.

Authors:  R E Gur; J J Yi; D M McDonald-McGinn; S X Tang; M E Calkins; D Whinna; M C Souders; A Savitt; E H Zackai; P J Moberg; B S Emanuel; R C Gur
Journal:  Mol Psychiatry       Date:  2014-01-21       Impact factor: 15.992

5.  Categorical versus dimensional approaches to autism-associated intermediate phenotypes in 22q11.2 microdeletion syndrome.

Authors:  Maria Jalbrzikowski; Khwaja Hamzah Ahmed; Arati Patel; Rachel Jonas; Leila Kushan; Carolyn Chow; Carrie E Bearden
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-01

6.  Ranbp1, Deleted in DiGeorge/22q11.2 Deletion Syndrome, is a Microcephaly Gene That Selectively Disrupts Layer 2/3 Cortical Projection Neuron Generation.

Authors:  Elizabeth M Paronett; Daniel W Meechan; Beverly A Karpinski; Anthony-Samuel LaMantia; Thomas M Maynard
Journal:  Cereb Cortex       Date:  2014-12-01       Impact factor: 5.357

Review 7.  Developmental trajectories in 22q11.2 deletion.

Authors:  Ann Swillen; Donna McDonald-McGinn
Journal:  Am J Med Genet C Semin Med Genet       Date:  2015-05-18       Impact factor: 3.908

8.  Genetic contributions to changes of fiber tracts of ventral visual stream in 22q11.2 deletion syndrome.

Authors:  Zora Kikinis; Nikos Makris; Christine T Finn; Sylvain Bouix; Diandra Lucia; Michael J Coleman; Erica Tworog-Dube; Ron Kikinis; Raju Kucherlapati; Martha E Shenton; Marek Kubicki
Journal:  Brain Imaging Behav       Date:  2013-09       Impact factor: 3.978

Review 9.  22q11.2 deletion syndrome.

Authors:  Donna M McDonald-McGinn; Kathleen E Sullivan; Bruno Marino; Nicole Philip; Ann Swillen; Jacob A S Vorstman; Elaine H Zackai; Beverly S Emanuel; Joris R Vermeesch; Bernice E Morrow; Peter J Scambler; Anne S Bassett
Journal:  Nat Rev Dis Primers       Date:  2015-11-19       Impact factor: 52.329

10.  22q11.2 Deletion Syndrome due to a Translocation t(6;22) in a Patient Conceived via in vitro Fertilization.

Authors:  Anelisa Gollo Dantas; Adriana Bortolai; Mariana Moysés-Oliveira; Sylvia Takeno Herrero; Adriana Azoubel Antunes; Beatriz Tavares Costa-Carvalho; Vera Ayres Meloni; Maria Isabel Melaragno
Journal:  Mol Syndromol       Date:  2015-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.